Literature DB >> 26118438

Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols.

Christopher B Anderson1, Amy L Tin2, Daniel D Sjoberg2, John P Mulhall1, Jaspreet Sandhu1, Karim Touijer1, Vincent P Laudone1, James A Eastham1, Peter T Scardino1, Behfar Ehdaie1,2.   

Abstract

OBJECTIVES: To evaluate whether the number of preoperative prostate biopsies affects functional outcomes after radical prostatectomy (RP).
METHODS: We identified patients treated with RP at our institution between 2008 and 2011. At 6 and 12 months postoperatively, the patients completed questionnaires assessing erectile and urinary function. Patients with preoperative incontinence or erectile dysfunction or who did not complete the questionnaire were excluded. Primary outcomes were urinary and erectile function at 12 months postoperatively. We used logistic regression to estimate the impact of number of prostate biopsies on functional outcomes after adjusting for demographic and clinical factors.
RESULTS: We identified 2 712 patients treated with RP between 2008 and 2011. Most of the patients (80%) had one preoperative prostate biopsy, 16% had two, and 4% had at least three. On adjusted analysis, erectile function at 12 months was not significantly different for patients with two (odds ratio [OR] 1.25; 95% confidence interval [CI] 0.90, 1.75) or three or more (OR 1.52; 95% CI 0.84, 2.78) biopsies, compared with those with one biopsy. Similarly, urinary function at 12 months was not significantly different for patients with two (0.84, 95% CI 0.64, 1.10) or three or more (0.99, 95% CI 0.60, 1.61) biopsies compared with those with one.
CONCLUSIONS: We did not find evidence that a greater number of preoperative prostate biopsies adversely affected erectile or urinary function at 12 months after RP.
© 2015 The Authors BJU International © 2015 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  TRUS prostate biopsy; erectile dysfunction; radical prostatectomy; urinary incontinence

Mesh:

Year:  2015        PMID: 26118438      PMCID: PMC4991927          DOI: 10.1111/bju.13215

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  29 in total

1.  The impact of multiple biopsies on outcomes of nerve-sparing robotic-assisted radical prostatectomy.

Authors:  P Sooriakumaran; A Calaway; D Sagalovich; S Roy; A Srivastava; J Joneja; M Shevchuk; A K Tewari
Journal:  Int J Impot Res       Date:  2012-04-26       Impact factor: 2.896

2.  Impact on quality of life of radical prostatectomy after initial active surveillance: more to lose?

Authors:  Roderick C N van den Bergh; Willem de Blok; Erik van Muilekom; Corinne Tillier; Lionne D Venderbos; Henk G van der Poel
Journal:  Scand J Urol       Date:  2014-02-10       Impact factor: 1.612

3.  A multi-institutional evaluation of active surveillance for low risk prostate cancer.

Authors:  Scott E Eggener; Alex Mueller; Ryan K Berglund; Raj Ayyathurai; Cindy Soloway; Mark S Soloway; Robert Abouassaly; Eric A Klein; Steven J Jones; Chris Zappavigna; Larry Goldenberg; Peter T Scardino; James A Eastham; Bertrand Guillonneau
Journal:  J Urol       Date:  2013-01       Impact factor: 7.450

4.  Active surveillance program for prostate cancer: an update of the Johns Hopkins experience.

Authors:  Jeffrey J Tosoian; Bruce J Trock; Patricia Landis; Zhaoyong Feng; Jonathan I Epstein; Alan W Partin; Patrick C Walsh; H Ballentine Carter
Journal:  J Clin Oncol       Date:  2011-04-04       Impact factor: 44.544

5.  Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment.

Authors:  Mark S Soloway; Cynthia T Soloway; Ahmed Eldefrawy; Kristell Acosta; Bruce Kava; Murugesan Manoharan
Journal:  Eur Urol       Date:  2010-08-20       Impact factor: 20.096

6.  Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance.

Authors:  Kazutoshi Fujita; Patricia Landis; Brian K McNeil; Christian P Pavlovich
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

7.  Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate.

Authors:  Ernesto Lopez-Corona; Makoto Ohori; Thomas M Wheeler; Victor E Reuter; Peter T Scardino; Michael W Kattan; James A Eastham
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

8.  Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.

Authors:  K Clint Cary; Janet E Cowan; Melissa Sanford; Katsuto Shinohara; Nannette Perez; June M Chan; Maxwell V Meng; Peter R Carroll
Journal:  Eur Urol       Date:  2013-09-09       Impact factor: 20.096

9.  Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.

Authors:  Laurence Klotz; Liying Zhang; Adam Lam; Robert Nam; Alexandre Mamedov; Andrew Loblaw
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

Review 10.  Systematic review of complications of prostate biopsy.

Authors:  Stacy Loeb; Annelies Vellekoop; Hashim U Ahmed; James Catto; Mark Emberton; Robert Nam; Derek J Rosario; Vincenzo Scattoni; Yair Lotan
Journal:  Eur Urol       Date:  2013-06-04       Impact factor: 20.096

View more
  2 in total

1.  Improved Recovery of Erectile Function in Younger Men after Radical Prostatectomy: Does it Justify Immediate Surgery in Low-risk Patients?

Authors:  Justin K Lee; Daniel D Sjoberg; Mariam Imnadze Miller; Andrew J Vickers; John P Mulhall; Behfar Ehdaie
Journal:  Eur Urol       Date:  2017-08-26       Impact factor: 20.096

2.  Surgical and functional outcomes of radical retropubic prostatectomy after biopsy-related acute prostatitis.

Authors:  Şükrü Kumsar; Emre Karabay; Omer Yüksel; Feridun Şengör
Journal:  Cent European J Urol       Date:  2019-01-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.